Non-Viral Drug Delivery Systems

 The domain is currently dominated by the presence of small players (40%). Examples include ( in alphabetical order, based in North America ), Acuitas Therapeutics, XXX, XXX, Carmine Therapeutics and Sisaf. This is followed by very small players, which represent nearly 30% of the total industry players. Moreover, the majority of small players (35%) are present within the North American and European regions, followed by very small players (24%) and mid-sized players (20%). It is interesting to note that 65% of the players were privately held firms followed by the firms (35%) which are public organizations.\ Even though non-viral drug delivery systems are being offered by players based all across the globe, most of the players engaged in this domain (52%) are headquartered in North America, followed by Europe, Asia, Middle East and North Africa, and the rest of the world. Further, a large portion (44%) of players were established between 2005 to 2015, this is followed by companies (3...